20 May 2010
Brain MRI findings in preterm babies versus transfontanel sonography-own experience
Monika Bekiesinska-Figatowska, Ewa Helwich, Hanna Bragoszewska, Anna Romaniuk-Doroszewska, Magdalena Rutkowska, Sylwia Szkudlinska-Pawlak, Ewa Adamska, Malgorzata DzwonkowskaMed Sci Monit 2010; 16(1): 60-65 :: ID: 880585
Abstract
Background: Preterm babies are at high risk for adverse neurodevelopmental outcomes. Bipolar opinions can still be found on ultrasonography (US) and magnetic resonance imaging (MRI) in detecting brain injury. This study compared the usefulness of both imaging methods and assessed their value in long-term prognosis.
Material/Methods: Twenty-five infants were born between the 22nd and 32nd week of pregnancy: 12 girls, 13 boys. They underwent US examinations (1–12 times) and MRI at term equivalent. MRI was performed with a 1.5 T scanner without sedation. SE/T1-, T2 flair, FSE/T2-, GRE/T2*-weighted images, and DWI were obtained.
Results: MRI provided more details in 6/25 babies. In 1 baby, posterior fossa abnormalities were observed only on MRI. One MRI revealed thin, hypoplastic corpus callosum, while US showed only its anterior part. Cystic white matter lesions were not detected on US in 2 babies, 2 cysts were bilateral on MRI, while unilateral on US. Sonographic diagnosis of 1 cyst was ruled out by MRI. Posthemorrhagic lesions were found on MRI in 3 infants; in 2, they were bilateral; while on US they were unilateral. In 2, cerebellar hemorrhage was visualized only on MRI. In 1 baby, delay in myelination was observed at term equivalent.
Conclusions: MRI at term equivalent proved to be a more sensitive method of detecting hypoxic-ischemic brain injury, cerebral hemorrhage, and congenital anomalies than serial US in preterm infants. Follow-up studies in 2 years will assess the natural history of brain lesions and correlate the neurologic status of children and their brain appearance.
Keywords: ultrasonography (US), Magnetic Resonance Imaging (MRI), Brain, preterm baby
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952